{"id":226723,"date":"2026-09-02T10:01:20","date_gmt":"2026-09-02T04:31:20","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=226723"},"modified":"2026-09-02T10:01:20","modified_gmt":"2026-09-02T04:31:20","slug":"why-ipca-laboratories-ltd-share-52-week-consecutive-high-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-ipca-laboratories-ltd-share-52-week-consecutive-high-2026\/","title":{"rendered":"Ipca Laboratories Ltd. (IPCALAB): Ipca Laboratories 52 Week High Streak: What the second straight session signals"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/ipcalab\/ipca-laboratories-ltd-share-price-today\">Ipca Laboratories Ltd. (IPCALAB)<\/a> share price reached a fresh 52-week high of Rs 1,999 today and later stood at Rs 1,958.6, down 1.38% from the previous close. Market cap was Rs 50,109.12 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\"><a href=\"https:\/\/univest.in\/stocks\/ipcalab\/ipca-laboratories-ltd-share-price-today\">Ipca Laboratories Ltd. (IPCALAB)<\/a> has now set a fresh 52-week high for its second straight session, with the stock touching Rs 1999 and closing at Rs 1958.6 in the latest trade. Across the streak, the cumulative move is -0.84%, according to the supplied data. The pattern confirms repeated one-year highs, but the data does not establish a company-specific catalyst for the continuation of the move.<\/p>\n<p style=\"margin-top:0!important;\">Against the previous close of Rs 1985.95, the stock ended lower by Rs 27.35 or 1.38%. The session opened at Rs 1964.55 and moved between Rs 1958.6 and Rs 1999, with turnover at Rs 0.58 crore and market capitalisation at Rs 50109.12 crore. For readers, a repeated-high pattern is more informative than a single-day breakout because it shows the stock is continuing to print new one-year peaks across sessions, even though the supplied data does not explain why.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-ipca-laboratories-ltd-share-52-week-consecutive-high-2026\/#Ipca_Laboratories_52_Week_High_Streak_Consecutive_High_Analysis\" title=\"Ipca Laboratories 52 Week High Streak: Consecutive High Analysis\">Ipca Laboratories 52 Week High Streak: Consecutive High Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-ipca-laboratories-ltd-share-52-week-consecutive-high-2026\/#What_the_Repeated_52-Week_Highs_Show\" title=\"What the Repeated 52-Week Highs Show\">What the Repeated 52-Week Highs Show<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-ipca-laboratories-ltd-share-52-week-consecutive-high-2026\/#Ipca_Laboratories_Ltd_IPCALAB_Fundamental_Analysis\" title=\"Ipca Laboratories Ltd. (IPCALAB) Fundamental Analysis\">Ipca Laboratories Ltd. (IPCALAB) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-ipca-laboratories-ltd-share-52-week-consecutive-high-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-ipca-laboratories-ltd-share-52-week-consecutive-high-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-ipca-laboratories-ltd-share-52-week-consecutive-high-2026\/#Why_Investors_Are_Watching\" title=\"Why Investors Are Watching\">Why Investors Are Watching<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-ipca-laboratories-ltd-share-52-week-consecutive-high-2026\/#About_the_Company\" title=\"About the Company\">About the Company<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-ipca-laboratories-ltd-share-52-week-consecutive-high-2026\/#Track_Ipca_Laboratories_on_Univest\" title=\"Track Ipca Laboratories on Univest\">Track Ipca Laboratories on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-ipca-laboratories-ltd-share-52-week-consecutive-high-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-ipca-laboratories-ltd-share-52-week-consecutive-high-2026\/#What_does_Ipca_Laboratories_52_Week_High_Streak_mean\" title=\"What does Ipca Laboratories 52 Week High Streak mean?\">What does Ipca Laboratories 52 Week High Streak mean?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-ipca-laboratories-ltd-share-52-week-consecutive-high-2026\/#How_many_sessions_has_Ipca_Laboratories_set_a_fresh_52-week_high\" title=\"How many sessions has Ipca Laboratories set a fresh 52-week high?\">How many sessions has Ipca Laboratories set a fresh 52-week high?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-ipca-laboratories-ltd-share-52-week-consecutive-high-2026\/#What_is_the_current_52-week_high_for_Ipca_Laboratories\" title=\"What is the current 52-week high for Ipca Laboratories?\">What is the current 52-week high for Ipca Laboratories?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-ipca-laboratories-ltd-share-52-week-consecutive-high-2026\/#Is_the_company-specific_catalyst_confirmed_by_the_data\" title=\"Is the company-specific catalyst confirmed by the data?\">Is the company-specific catalyst confirmed by the data?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-ipca-laboratories-ltd-share-52-week-consecutive-high-2026\/#Is_Ipca_Laboratories_expensive_compared_with_peers\" title=\"Is Ipca Laboratories expensive compared with peers?\">Is Ipca Laboratories expensive compared with peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-ipca-laboratories-ltd-share-52-week-consecutive-high-2026\/#What_should_investors_monitor_next_in_Ipca_Laboratories_stock_news\" title=\"What should investors monitor next in Ipca Laboratories stock news?\">What should investors monitor next in Ipca Laboratories stock news?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-ipca-laboratories-ltd-share-52-week-consecutive-high-2026\/#Track_Ipca_Laboratories_Ltd_IPCALAB_Share_Price_on_Univest\" title=\"Track Ipca Laboratories Ltd. (IPCALAB) Share Price on Univest\">Track Ipca Laboratories Ltd. (IPCALAB) Share Price on Univest<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Ipca_Laboratories_52_Week_High_Streak_Consecutive_High_Analysis\"><\/span><strong>Ipca Laboratories 52 Week High Streak: Consecutive High Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,958.6<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,985.95<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs -27.35 (-1.38%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,964.55<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,999<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,958.6<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 0.58 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 50,109.12 crore<\/td>\n<\/tr>\n<\/table>\n<p>Ipca Laboratories Ltd. (IPCALAB) traded at Rs 1,958.6 versus the previous close of Rs 1,985.95, a fall of 1.38%. The stock opened at Rs 1,964.55, reached a high of Rs 1,999 and touched a low of Rs 1,958.6.<\/p>\n<p>Ipca Laboratories\u2019 share price today finished below the previous close, even as the stock retained its fresh 52-week high status for a second straight session. The close at Rs 1958.6 was Rs 27.35 or 1.38% lower than Rs 1985.95, which places the day\u2019s end nearer the bottom of the range than the top. The stock opened at Rs 1964.55, touched a high of Rs 1999 and a low of Rs 1958.6, so the close matched the session low.<\/p>\n<p>That range matters because it shows where the stock spent the session after setting a new one-year peak. The latest high of Rs 1999 is also the current 52-week high, and the repeated print across consecutive sessions is the main event here. Turnover stood at Rs 0.58 crore, while market capitalisation was Rs 50109.12 crore. On the numbers alone, the Ipca Laboratories share price today reflects a stock that has stayed close to its high zone, even though the latest close was softer than the previous day\u2019s finish.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_the_Repeated_52-Week_Highs_Show\"><\/span><strong>What the Repeated 52-Week Highs Show<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Ipca Laboratories 52 Week High Streak now stands at a second straight session, which is the key pattern to watch. The main factual takeaway is that the stock has not just reached a one-year high once; it has repeated the feat on consecutive trading days. Across this streak, the cumulative move supplied by the workflow is -0.84%, which means the extended streak has not been accompanied by a net gain over the full measured period.<\/p>\n<p>That distinction is important. A new high on one day can be a sharp event, but a repeated-high sequence across sessions gives a better read on whether the stock is still holding near its peak area. In this case, the latest 52-week high of Rs 1999 is the same as the day\u2019s high, while the close remained below that level. The supplied data confirms the price pattern, but it does not establish a fresh company-specific trigger behind the continuation. For investors tracking Ipca Laboratories 52 Week High Streak, the relevant question is whether the stock can keep closing near the high zone rather than only printing it intraday.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Ipca_Laboratories_Ltd_IPCALAB_Fundamental_Analysis\"><\/span><strong>Ipca Laboratories Ltd. (IPCALAB) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 50,109.12 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">38.47x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">5.94x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">15.88%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">19.41%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 51.63<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 334.38<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.3%<\/td>\n<\/tr>\n<\/table>\n<p>Ipca Laboratories Ltd. (IPCALAB) fundamental metrics show P\/E 38.47x, P\/B 5.94x, ROE 15.88%, ROCE 19.41%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Ipca Laboratories Ltd. has a market capitalisation of Rs 50109.12 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 38.47x, P\/B at 5.94x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 15.88% and ROCE of 19.41%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 51.63, book value per share of Rs 334.38, dividend yield of 0.3%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P\/E of 31.13x, median ROE of 11.78%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">38.47x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">31.13x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">48.18x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.68x to 653.31x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">5.94x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.87x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">15.88%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.78%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">19.41%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.61%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 50,109.12 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 698.8 crore<\/td>\n<\/tr>\n<\/table>\n<p>Ipca Laboratories Ltd. (IPCALAB) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Ipca Laboratories Ltd. (IPCALAB) has a P\/E ratio of 38.47x, which is above the benchmark median of 31.13x, a difference of +23.58%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Ipca Laboratories Ltd. (IPCALAB) has a ROE of 15.88%, which is above the benchmark median of 11.78%, a difference of +34.8%. Ipca Laboratories Ltd. (IPCALAB) has a ROCE of 19.41%, which is above the benchmark median of 13.61%, a difference of +42.62%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/anthem\/anthem-biosciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Anthem Biosciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ANTHEM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">50,227.82<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">90.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.62<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.98<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">29.62<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/glaxo\/glaxosmithkline-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Glaxosmithkline Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">GLAXO<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">51,721.36<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">47.5<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">20.13<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">48.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">66.79<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><strong>Gland Pharma Ltd.<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">GLAND<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">47,647.32<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">41.92<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.45<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.56<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.96<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/abbotindia\/abbott-india-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Abbott India Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ABBOTINDIA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">54,942.41<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">34.4<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.73<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">34.67<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">46.72<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/ajantpharm\/ajanta-pharma-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Ajanta Pharma Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">AJANTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">45,237.67<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">38.59<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9.02<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">25.42<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">32.67<\/td>\n<\/tr>\n<\/table>\n<p>Ipca Laboratories Ltd. (IPCALAB) has a P\/E ratio of 38.47x compared with the displayed peer median of 41.92x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 15.88% compares with a peer median of 25.42% across the companies shown in the table. ROCE stood at 19.41% versus the displayed peer median of 32.67%, providing a capital-efficiency comparison. Ipca Laboratories Ltd. (IPCALAB) has a market capitalisation of Rs 50,109.12 crore. Among the 5 peers shown, 3 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching\"><\/span><strong>Why Investors Are Watching<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>The stock has set a fresh 52-week high for a second straight session, which keeps the Ipca Laboratories 52 Week High Streak in focus.<\/li>\n<li>The latest high of Rs 1999 is the current one-year peak, while the close at Rs 1958.6 was below that level.<\/li>\n<li>The cumulative streak move supplied for the event is -0.84%, which makes the repeated-high pattern more important than the net gain alone.<\/li>\n<li>The valuation sits above the same-industry median on both P\/E and P\/B, so investors can compare price with fundamentals.<\/li>\n<li>The company\u2019s ROE and ROCE are both above the peer medians, which gives the Ipca Laboratories stock news flow a fundamentals angle.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_the_Company\"><\/span><strong>About the Company<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Ipca Laboratories Ltd. operates in the Pharmaceuticals &#038; Drugs industry within the Healthcare sector. The company is tracked on NSE and BSE as IPCALAB, and the latest market capitalisation supplied is Rs 50109.12 crore. In a stock market article like this, the focus is on the quoted market data, valuation and ownership structure rather than product-level details.<\/p>\n<p>The company\u2019s reported financial metrics in the supplied dataset include revenue-related references through valuation and return measures, along with EPS of Rs 51.63, book value of Rs 334.38, ROE of 15.88 and ROCE of 19.41. For readers following Ipca Laboratories stock performance, these figures help frame the current streak against the company\u2019s underlying financial profile. The latest share price update should therefore be read alongside its fundamental and peer context, not in isolation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Ipca_Laboratories_on_Univest\"><\/span><strong>Track Ipca Laboratories on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Track Ipca Laboratories on Univest for the latest Ipca Laboratories share price, stock news, stock analysis and market update. The Ipca Laboratories 52 Week High Streak will remain relevant as long as the stock continues to print fresh one-year highs across sessions. Readers can follow the same stock page for future price action and company news.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_does_Ipca_Laboratories_52_Week_High_Streak_mean\"><\/span><strong>What does Ipca Laboratories 52 Week High Streak mean?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> It means the stock has set a fresh 52-week high on consecutive sessions. In this case, Ipca Laboratories has done so for a second straight session, which is the key factual streak event.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_many_sessions_has_Ipca_Laboratories_set_a_fresh_52-week_high\"><\/span><strong>How many sessions has Ipca Laboratories set a fresh 52-week high?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Ipca Laboratories has set a fresh 52-week high for two consecutive trading sessions. The supplied streak label is, second straight session,, which is the exact framing to use. The stock moved -1.38% during the session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_current_52-week_high_for_Ipca_Laboratories\"><\/span><strong>What is the current 52-week high for Ipca Laboratories?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The current 52-week high supplied for Ipca Laboratories is Rs 1999. The stock touched that level in the latest session, making it the repeated one-year peak in the streak. The stock moved -1.38% during the session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_the_company-specific_catalyst_confirmed_by_the_data\"><\/span><strong>Is the company-specific catalyst confirmed by the data?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. The supplied data confirms the repeat 52-week high pattern, but it does not establish a specific company-triggered reason for the continued move. Readers should separate the price pattern from the cause.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Ipca_Laboratories_expensive_compared_with_peers\"><\/span><strong>Is Ipca Laboratories expensive compared with peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The stock trades above the same-industry median on P\/E and P\/B, so it is not priced cheaply relative to the supplied peer set. However, its ROE and ROCE are also above the peer medians.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_investors_monitor_next_in_Ipca_Laboratories_stock_news\"><\/span><strong>What should investors monitor next in Ipca Laboratories stock news?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors should track whether the stock continues to hold near the latest one-year high, whether the streak extends, and whether future company updates or financial results change the valuation view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Ipca_Laboratories_Ltd_IPCALAB_Share_Price_on_Univest\"><\/span><strong>Track Ipca Laboratories Ltd. (IPCALAB) Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/ipcalab\/ipca-laboratories-ltd-share-price-today\">Ipca Laboratories Ltd. (IPCALAB) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ipca Laboratories Ltd. Share Price hits a new 52-week high at Rs 1,958.6. marking a -1.38% rise today. Market cap stands at Rs 50,109.12 crore.<\/p>\n","protected":false},"author":29,"featured_media":226721,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-226723","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["226721"],"rank_math_title":["Ipca Laboratories 52 Week High Streak: Valuation and Peers"],"rank_math_description":["Ipca Laboratories has set a fresh 52-week high for a second straight session. See the cumulative move, valuation, peers and what to watch next."],"rank_math_focus_keyword":["Ipca Laboratories 52 Week High Streak"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/Ipca_Laboratories_Ltd_IPCALAB_Ipca_Laboratories_52_Week_High_Streak_What_the_second_straight_session_signals_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/226723","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=226723"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/226723\/revisions"}],"predecessor-version":[{"id":226725,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/226723\/revisions\/226725"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/226721"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=226723"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=226723"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=226723"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}